Back to UBS Group AG UBS Group AG

BIO/B

23 quarters

Position history for UBS Group AGUBS Group AG's holdings in Bio-Rad Laboratories, Inc.

Yes. Ubs holds 13 shares of BIO/B (Bio-Rad Laboratories), worth $3,913, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Ubs has held BIO/B since Q4 2025, across 3 quarterly 13F filings.

Current Value

$3,913

Current Shares

13

Total Value Change

-$171,087

Total Shares Change

-559

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
13
0.0%
$3,9130.0%$296.49
0
2026-Q1
Increased
13
+62.5%
$3,6170.0%$278.25
14
2025-Q4
New
8
-
$2,3880.0%$310.70
19
2025-Q3
Exited
0
-100.0%
$00.0%$284.88
0
2025-Q2
Increased
3
+200.0%
$7160.0%$250.08
12
2025-Q1
Unchanged
1
0.0%
$2420.0%$241.99
0
2024-Q4
New
1
-
$3230.0%$325.60
17
2023-Q1
Exited
0
-100.0%
$00.0%$464.10
0
2022-Q4
Increased
36
+3500.0%
$14,8320.0%$404.66
20
2022-Q3
New
1
-
$00.0%$418.65
17
2022-Q1
Exited
0
-100.0%
$00.0%$587.56
0
2021-Q4
Increased
299
+208.3%
$226,0000.0%$722.91
37
2021-Q3
Increased
97
+259.3%
$72,0000.0%$759.91
23
2021-Q2
Decreased
27
-32.5%
$17,0000.0%$640.00
0
2021-Q1
New
40
-
$23,0000.0%$579.38
29
2020-Q4
Exited
0
-100.0%
$00.0%$574.15
0
2020-Q3
Increased
303
+45.7%
$154,0000.0%$508.00
30
2020-Q2
Increased
208
+119.0%
$94,0000.0%$436.97
24
2020-Q1
Decreased
95
-83.4%
$33,0000.0%$351.32
0
2019-Q4
Unchanged
572
0.0%
$212,0000.0%$369.60
0
2019-Q3
Unchanged
572
0.0%
$190,0000.0%$340.54
0
2019-Q2
Unchanged
572
0.0%
$179,0000.0%$306.18
0
2019-Q1
First report
572
-
$175,0000.0%$303.00
0

Other major holders of BIO/B: Royal London Asset Management Ltd., Renaissance Technologies LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used